Clinical Trial: A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07170150) titled 'A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease' on Sept. 10.

Brief Summary: The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease (AD) (mild cognitive impairment [MCI] to mild dementia due to AD).

Study Start Date: Oct. 27

Study Type: INTERVENTIONAL

Condition: Alzheimers Disease

Intervention: DRUG: Trontinemab

Participants will receive IV trontinemab

OTHER: Placebo

Participants will receive IV placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Hoffmann-La Roche

Published by HT Digital Conte...